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Abstract
Background: Seasonal mortality differences have been reported in US hemodialysis (HD) patients. Here we
examine the effect of seasons on mortality, clinical and laboratory parameters on a global scale.
Methods: Databases from the international Monitoring Dialysis Outcomes (MONDO) consortium were queried to
identify patients who received in-center HD for at least 1 year. Clinics were stratified by hemisphere and climate
zone (tropical or temperate). We recorded mortality and computed averages of pre-dialysis systolic blood pressure
(pre-SBP), interdialytic weight gain (IDWG), serum albumin, and log C-reactive protein (CRP). We explored seasonal
effects using cosinor analysis and adjusted linear mixed models globally, and after stratification.
Results: Data from 87,399 patients were included (northern temperate: 63,671; northern tropical: 7,159; southern
temperate: 13,917; southern tropical: 2,652 patients). Globally, mortality was highest in winter. Following
stratification, mortality was significantly lower in spring and summer compared to winter in temperate, but not in
tropical zones. Globally, pre-SBP and IDWG were lower in summer and spring as compared to winter, although less
pronounced in tropical zones. Except for southern temperate zone, serum albumin levels were higher in winter.
CRP levels were highest in winter.
Conclusion: Significant global seasonal variations in mortality, pre-SBP, IDWG, albumin and CRP were observed.
Seasonal variations in mortality were most pronounced in temperate climate zones.
Keywords: Blood pressure, Global, Hemodialysis, Interdialytic weight gain, Seasonal patterns, Survival
Background
Biological rhythms underlie multiple physiological pro-
cesses. This also holds true for dialysis patients in whom
disturbances in oscillatory rhythms are of major patho-
physiologic importance. Most attention in the dialysis
literature has been directed to alterations in ultradian
(periods less than 20 h) and circadian (periods between
20 and 28 h) rhythms [1]. However recent studies
showed that infradian rhythms (periods longer than 28 h)
also have major significance in this population [2–4].
Various clinical and laboratory parameters were found
to differ between seasons: in several series both blood
pressure and interdialytic weight gain (IDWG) were
significantly lower during the summer as compared to
the winter [2, 3, 5–7].
Recently we showed in a large cohort of United
States (US) hemodialysis (HD) patients that mortality
was significantly higher in winter as compared to sum-
mer [2]. Moreover IDWG, pre-dialysis systolic blood
pressure (pre-SBP) and laboratory parameters such as the
neutrophil-lymphocyte ratio (NLR) were also significantly
higher in winter. The clinical importance of circannual
cycles is further supported by the fact that some of the
seasonally variable parameters like IDWG, blood pressure
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or markers of inflammation are potentially amenable to
intervention.
Until now, all studies on seasonal variation in clinical
and laboratory parameters in dialysis patients as well as
outcome have been performed in temperate climate zones
and it is unknown whether these results are applicable in
other major climate zones, when analyzed at a global
level. The season and/or its associated temperature differ-
ences appear to be an important determinant of mortality
as demonstrated in the general population in different
continents and therefore of importance from a global
health perspective [8].
Recently the Monitoring Dialysis Outcomes (MONDO)
initiative was initiated with the explicit goal to better
understand biological factors and outcomes in chronic
dialysis patients. MONDO is an international consortium
of dialysis providers from Asia, South America, Europe,
and the US [9, 10]. In this global repository, data can be
analyzed on a patient level, which allows for the analysis
of relevant epidemiological trends in various geographical
locations, in patients with diverse ethnicities as well as
regions with different practice patterns. The fact that
clinics of MONDO partners reside in both Northern and
Southern hemispheres and in different climatic zones
provides a unique opportunity to study seasonal patterns
in mortality and important clinical parameters on a glo-
bal scale.
In this analysis we studied seasonal variations of indi-
cators with relevance to nutritional, cardiovascular and
inflammatory domains, namely IDWG, pre-SBP, serum
albumin and C-reactive protein (CRP). The aim of this
study was to assess seasonal variations in mortality and
selected clinical and laboratory parameters, both globally
and after stratification in hemispheres and major climate
zones across the globe.
Methods
At the time of analysis, MONDO consisted of HD
databases from Renal Research Institute (RRI) clinics in
the US, Fresenius Medical Care (FMC) clinics in
Canada, Europe, Asia Pacific (AP) and Latin America
(LA), Kuratorium für Dialyse und Nierentransplantation
(KfH) clinics in Germany, Imperial College in United
Kingdom (UK), Hadassah Medical Center in Israel
and Maastricht University Medical Center in The
Netherlands. This present study is a retrospective data
base analysis; no a priori inclusion or exclusion criteria
were applied. We queried databases from RRI, FMC
Europe (17 countries), FMC AP (9 countries) and FMC
LA (5 countries) to identify all HD patients who had
in-center HD treatments for at least 1 year between
Jan 1, 2000 and Sep 30, 2012. MONDO database includes
information on all patients treated in the respective
provider network with the data directly extracted from the
electronic health record systems. Every individual provider
has its own procedures for data cleaning before data end
up in the respective provider system. For data collection
and analysis, local ethical, compliance, and legal standards
are followed. Research conducted by MONDO complies
with the Declaration of Helsinki. MONDO partner orga-
nizations are responsible for the primary collection and
safeguarding of patient data in accordance with all applic-
able local data protection laws and privacy protection
regulations. They also ensure full compliance with laws
and regulations regarding the secondary use of data in the
context of MONDO. The MONDO data base contains
only de-identified data. The New England Institutional
Review Board (IRB) has reviewed the claim of exemption
for the study and has determined that this research activ-
ity is exempt from IRB review Additional file 1 [9, 10].
For each dialysis clinic the major climate zone was
identified. We stratified patients into those treated in the
Northern and Southern hemisphere respectively, and by
tropical and temperate climates. According to standard
geographical convention the tropical zone covers the
latitudes between 23.5° North and 23.5° South whereas
the temperate zone covers the latitudes between 23.5°
and 66.5° on the Northern and Southern hemispheres,
respectively. No clinics were located in frigid zones
(beyond 66.5° North or South, respectively).
In order to correct for geographical region within these
zone we used the United Nations (UN) geo-scheme
model [11]. We distinguished the following regions:
North America, South America, Eastern Asia, Southeast-
ern Asia and Western Asia. Europe was divided into
Eastern, Northern, Southern and Western parts. Oceania
included Australia and New Zealand.
Seasons were defined based on the calendar months.
In the Northern hemisphere, winter was defined as
December through February, spring as March through
May, summer as June to August, and fall as September
to November. In the Southern hemisphere, winter was
defined as December through February, spring as March
through May, summer as June to August, and fall as
September to November.
We computed on a per-patient level and per season
mean pre-SBP, IDWG (expressed as percent of post-
dialysis weight, IDWG %), log CRP and serum albumin
levels. Average values for each season, for each year and
for each patient were considered. Only patients with at
least one treatment in each of the four seasons were
included.
We constructed cosinor models to explore whether
cyclical seasonal trends exist in the data.
Cosinor is a set of simple functions that transforms
longitudinal data to estimate the cosinor linear model as
described in Tong [12]. Methods are given to summarize
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the mean, amplitude and acrophase, to predict the mean
annual outcome value, and to test the coefficients. To
determine the impact of seasonality on patient parame-
ters we additionally constructed linear mixed models
with random patient-specific intercept for continuous
variables with season as a predictor. Linear mixed models
were adjusted for treatment year (as categorical variable)
and UN geographic region (as categorical variable),
hemisphere and climate type (tropical and temperate),
to identify whether global changes were not attributed
to single treatment years or to a dominant influence
of individual regions. Additionally, the models were
constructed separately for Northern and Southern he-
mispheres, and for temperate and tropical climates.
To determine the impact of seasonality on patient mor-
tality we conducted a comparable analysis except that we
included all patients irrespective of the number of seasons
they were treated in. Cosinor analysis was performed for
a visual demonstration of mortality variations between
seasons. In addition, the association between seasons and
mortality was assessed by a proportional odds model with
death as the outcome and the season in which the patient
died as the predictor variable with adjustment for treat-
ment year (as categorical variable), UN geographic region
(as categorical variable), age, gender, vintage, diabetic
status, pre-dialysis systolic blood pressure, interdialytic
weight gain, albumin, hemisphere and climate zone. No
adjustments for CRP were made, because it was not
available in all regions.
An additional analysis was performed after stratifica-
tion by hemisphere and climate zone. This analysis was
performed both unadjusted and after adjustment for
treatment year (as categorical variable), UN geographic
region (as categorical variable), age, gender, vintage,
diabetic status, pre-dialysis systolic blood pressure, inter-
dialytic weight gain and albumin.
Lastly, this analysis was repeated after stratification for
climate zone only.
The score test for the proportional odds assumption
was not considered significant with p-value of >0.05. The
statistical analyses were conducted using SAS version 9.3
(SAS Institute, Cary, NC).
Results
We studied 87,399 patients (geographical distribution
and patient characteristics are shown in Table 1). Mean
age of the patients was lower in tropical regions, where
serum albumin and blood pressure levels were signifi-
cantly higher.
Seasonal variations in mortality
Cosinor analysis in the overall group indicated clear
differences in seasonal mortality (Fig. 1a). These results
were substantiated by the proportional odds model and
remained significant after adjustment for hemisphere,
climate, pre-SBP, albumin, and IDWG (Fig. 1b).
When separated by region and climate zone, unadjusted
analysis by the proportional odds model showed that in
temperate climates in both hemispheres mortality was
lower in spring and summer as compared to winter (fall
also lower in Southern temperate zone): North temperate
spring odds ratio (OR) 0.89 (0.85–0.94 95 % CI), summer
0.91 (0.86–0.95 95 % CI), fall 0.95 (0.91–1.00 95 % CI).
South temperate spring OR 0.82 (0.76–0.97 95 % CI),
summer 0.82 (0.76–0.87 95 % CI), fall 0.83 (0.78–0.89
95 % CI). In the tropical climates, mortality was not show
significantly different between seasons (with the exception
of spring mortality being lower in the Northern tropical
climate, (Fig. 1c). After adjustment for multiple con-
founders, mortality differences only persisted in the
Northern temperate zone (Fig. 1d). Lastly, in the analysis
pooling both tropical (North and South hemisphere) and
temperate (North and South hemispheres), adjusted sea-
sonal variations were only significant in the pooled tem-
perate zone: spring: OR 0.84 (0.78–0.91 95 % CI),
summer: OR 0.82 (CI 0.76–0.88) and autumn: OR 0.91
(OR 0.84–0.98). In the pooled tropical zones, despite a
tendency to higher mortality in the winter period:
seasonal variations did not reach significance: spring OR
Table 1 Patient characteristics by hemisphere and climate
Hemisphere Climate zone N Age (years) % Male % Diabetic Pre-SBP (mmHg) Albumin (g/dL) log CRP (mg/L) IDWG (% of post-weight)
Northern Temperate 63671 59.5 (16.5) 58.1 26.7 140 (20.2) 3.8 (0.5) 1.5 (1.6) 2.5 (1.7)
Tropical 7159 53.7 (16.6) 63.5 N/A 146.9 (20.2) 3.9 (0.5) 1.3 (1.9) 2.6 (2.3)
Total 70830 59 (16.6) 58.5 26.7 140.8 (20.4) 3.8 (0.5) 1.5 (1.6) 2.6 (1.8)
Southern Temperate 13917 57.6 (16.7) 57.3 29.2 134.2 (20.5) 3.6 (0.5) 2 (1.5) 2.8 (2.2)
Tropical 2652 50.4 (16.3) 59.8 N/A 141.5 (17.5) 3.9 (0.4) 0.2 (1.6) 4.1 (1.7)
Total 16569 56.4 (16.9) 57.8 29.2 135.5 (20.2) 3.7 (0.5) 1.9 (1.6) 3.1 (2.2)
Total 87399 58.4 (16.7) 58.4 27.2 139.5 (20.4) 3.8 (0.5) 1.6 (1.6) 2.6 (1.9)
Numbers indicate mean (SD) or percent
CRP C-reactive protein, IDWG interdialytic weight gain, SBP systolic blood pressure
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0.81 (0.63–1.02 95 % CI), summer: OR 0.84 (CI 0.66–
1.07) and autumn: OR 0.96 (OR 0.76–1.21).
Seasonal variations in pre-SBP and IDWG
Also a clear seasonal trend for pre-SBP was observed
using cosinor analysis (Fig. 2a), which was significant also
when adjusted for region and climate (Fig. 2b). When
separated by region and climate zone, pre-SBP was signifi-
cantly lower during summer both in tropical and temper-
ate climates in both hemispheres as compared to winter.
While significant, the pre-SBP difference between winter
and summer appeared less pronounced in tropical climate
zones (Fig. 2c).
Comparable trends were observed for IDWG (Fig. 3a–c),
with the lowest values observed during summer, and an
apparently smaller seasonal effect for tropical regions.
Seasonal variations in biochemical parameters
In general, serum albumin levels were higher during the
winter as compared to other seasons (Fig. 4a and b).
However, while albumin levels were significantly higher
during winter in tropical climates in both hemispheres
and in the North temperate climate (Fig. 4c), they were
lower during winter in South temperate climate.
In contrast, log-transformed CRP levels were highest
in winter (Fig. 5a and b). When analyzed separately by
hemisphere/climate region, CRP levels were signifi-
cantly lower in temperate climates in both hemispheres
in summer and spring compared to winter; fall levels
were less conclusive (Fig. 4a). In tropical climates sum-
mer CRP levels were also significantly lower than in
winter with patients manifesting significantly lower
CRP levels in this season compared to those in temperate
climates.
Fig. 1 Seasonal variations in mortality rate and odds ratios of death. a Actual mortality rate and estimated mortality rate using cosinor analysis
(global, unadjusted). b Relative risk of death (global, adjusted). c Odds ratios (95 % confidence intervals) of death separated per hemisphere, climate
zone and season (unadjusted). d Odds ratios (95 % confidence intervals) of death separated per hemisphere, climate and season (adjusted)
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Discussion
This study assessed seasonal variations in mortality and
important clinical and laboratory parameters in dialysis
patients in a large cohort of dialysis patients. This study
adds to the current body of knowledge by exploring for
the first time seasonal trends in dialysis patients on a
global basis, including countries of both Northern and
Southern hemispheres and of temperate and tropical
zones. The present study expands our previous observa-
tion of major seasonal differences in mortality in a large
cohort of chronic HD patients from the US [2].
At a global level, mortality was highest in winter and
lowest in spring and summer. In our previously studied
US cohort, mortality differences between seasons lost
statistical significance when adjusting for seasonally vari-
able risk factors such as blood pressure, albumin and
inter-dialytic weight gain. However, the present study had
far greater statistical power and clearly indicates that at a
global level seasonal differences remained significant after
adjustment for seasonally variable risk factors. Most
likely, other factors, such as underlying diseases, influence
seasonal mortality but are not reflected in the limited pal-
ette of clinical and laboratory parameters included in the
present study.
Following stratification and adjustment, seasonal varia-
tions in mortality appeared more pronounced in north-
ern temperate zones, whereas the variations in mortality
in tropical zones did not reach significance, although the
tendency to a higher winter mortality was also observed
in tropical regions. Admittedly, patient characteristics
differed between zones, but also after adjustment for
multiple confounders, seasonal variations in mortality
were only significant in the temperate zones, although
this.
Several general hypotheses can be put forward to explain
the apparent differences between climate zones. Firstly, in
tropical regions seasons are often more characterized by
differences in precipitation and not by classical four-
Fig. 2 Seasonal trends for pre-dialysis systolic blood presure. a Mean actual pre-dialysis systolic blood pressure and estimated pre-dialysis systolic
blood pressure using cosinor analysis (global, unadjusted). b Difference in pre-dialytic systolic blood pressure (95 % confidence intervals) between
seasons with winter as reference (global, adjusted). c Difference in pre-dialytic systolic blood pressure (95 % confidence intervals) between seasons
with winter as reference, separated by hemisphere and climate zone
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season’s patterns, with accompanying pronounced differ-
ences in seasonal temperature. Secondly, seasonal changes
in direct sunlight hours which might affect vitamin D
levels are less pronounced in tropical as compared to tem-
perate regions. Thirdly, both low winter temperatures and
high summer temperatures are also associated with mor-
tality in the general population [13, 14, 11], and the latter
effect may be more pronounced in tropical regions.
Our findings are in line with a recent study in general
population which showed that seasonal differences in
mortality in a US population were lowest in Miami, which
has a tropical climate [15]. On the other hand despite
much lower seasonal temperature differences, the variation
in cardiac mortality was comparable between Honolulu
and US cities located in temperate regions [16]. Lastly,
although the number of patients in each different zones
was substantial, the smaller number of patients in tropical
as compared to temperate regions might affect the margin
of error in the confidence intervals of mortality differences
between seasons, although the pooled tropical zones still
contained 9811 patients. Still, the potential differences in
seasonal mortality between the various climate zones
should be interpreted with caution.
Even in the general population comparative studies of
seasonal mortality in different global geographical zones
are scarce. In the ISOTHURM study mortality was higher
in winter periods, with more pronounced differences for
temperate as compared to tropical latitudes [8], showing a
significant relation between ambient temperature and
mortality. In contrast to the ISOTHURM study, ambient
outdoor and indoor temperatures were not available in
the present study. Therefore, we cannot make firm state-
ments about the relation between ambient temperature
and mortality [8].
The pathophysiological mechanisms underlying the
higher winter mortality rates in dialysis patients remain
Fig. 3 Seasonal trends for interdialytic weight gain. a Mean actual interdialytic weight gain percent and estimated interdialytic weight gain using
cosinor analysis (global). Interdialytic weight gain is expressed as % of post-dialysis weight. b Inter-dialytic weight difference (95 % confidence intervals)
between seasons with winter as reference (global, adjusted). Interdialytic weight gain is expressed as % of post-dialysis weight. c Inter-dialytic weight
gain difference (95 % confidence intervals) between seasons with winter as reference, separated by hemisphere and climate zone. Interdialytic weight
gain is expressed as % of post-dialysis weight
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hypothetical. In our previous US study, we found that
cardiovascular events, the most important cause of mor-
tality in dialysis patients, contributed predominantly to
the higher mortality in winter [2], an observation in
agreement with findings in the general population [8].
Both fluid overload, as indicated by higher IDWG,
increased peripheral vasoconstriction and release of pro-
thrombotic factors [17], as well as a higher incidence of
infectious complications and subsequent cardiovascular
complications [18], could be responsible for the ob-
served seasonal mortality differences. A recent study in
the general population showed that influenza epidemics
accounted for 18 % of the seasonal variation in cardiac
mortality [16]. Regrettably we were not able to deter-
mine the exact causes of death in the present cohort.
Also no data on vaccinations are available in our cohort.
Next to the differences in mortality, pre-SBP and IDWG
showed seasonal changes in all geographical zones. These
were observed both in temperate and - less pronounced -
tropical zones. Higher IDWG and pre-SBP have been
observed in winter periods in dialysis patients dwelling in
Northern [2, 3, 5] and Southern temperate zones [6]. To
the best of our knowledge only a single study from Brazil
addressed seasonal differences in blood pressure in a trop-
ical climate [19]. This study reported higher diastolic
and mean blood pressure in winter, but no difference
in IDWG between seasons. The mechanisms behind
seasonal differences in SBP have been discussed previously
and possibly include volume-related factors, differences in
vascular tone or differences in vitamin D3 levels [2, 3, 5, 6,
20]. The lower IDWG in summer could be related to
increased perspiration and/or differences in fluid intake.
Seasonal differences in serum albumin and CRP are
somewhat more difficult to interpret. At a global level,
CRP levels were lower in the summer period in all geo-
graphical zones, which may point to a lower risk of
Fig. 4 Seasonal trends for serum albumin. a Mean actual albumin (95 % CI) and estimated albumin using cosinor analysis (global, unadjusted).
b Serum albumin difference (95 % confidence intervals) between seasons with winter as reference (global, adjusted). c Serum albumin difference
(95 % confidence intervals) between seasons with winter as reference, separated by hemisphere and climate zone
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infectious episodes in summer periods [8]. The lower
CRP levels are in agreement with the lower neutrophil-
to-lymphocyte ratio (NLR) in summer which we observed
in our previous study [2]. A recent study from Dopico et
al. [21] showed a seasonal expression profile for more than
4,000 protein-coding mRNAs in white blood cells and adi-
pose tissue with inverted patterns observed between Eur-
ope and Oceania. They also found increased levels of
soluble IL-6 receptor and CRP during European winter,
risk biomarkers for cardiovascular and autoimmune dis-
eases with peak in winter. With the exception of southern
temperate regions, serum albumin levels were also lower
in the summer period. While these results contrast with
our previous study in US HD patients [2], in which no
seasonal differences in serum albumin levels were ob-
served, they are in agreement with findings from a Japa-
nese dialysis population [7]. The fact that serum albumin
levels, a strong marker of survival, were lower in the
season when the relative risk of death, as well as CRP
levels are also at their nadir appears contradictory. The
interpretation of serum albumin levels is complicated
since albumin concentrations are the compound resultant
of inflammation, nutrition, and fluid status. It is possible
that a higher dietary intake during winter [7] explains why
serum albumin levels are higher in this season. Data from
other studies are similarly inconclusive. In the study by
Cheung in North American patients [3], protein intake
appeared to be highest in early spring whereas serum
albumin levels were highest in October. From the present
results, we are not able to explain the discrepant results in
Southern temperate zones as data on dietary intake are
not available in our cohort. It is important to realize that
these observations only imply that in the population stud-
ied albumin levels are higher during winter, and not that
the relation between mortality and lower serum albumin
levels would be different in the MONDO population. In a
Fig. 5 Seasonal trends for log transformed C-reactive protein, ln (CRP). a Mean actual log (ln) of CRP (95 % CI) and estimated log of CRP using
cosinor analysis (global, unadjusted). b log (ln) C-reactive protein difference (95 % confidence intervals) between seasons with winter as reference
(global, adjusted). c log (ln) of C-reactive protein difference (95 % confidence intervals) between seasons with winter as reference, separated by
region and climate zone
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previous study from the MONDO cohort, we showed
significant declining temporal trends in serum albumin
levels before death [22].
The findings of the present study may have clinical
implications. Both pre-SBP and IDWG are related to
outcome in dialysis patients [23, 24]. Higher IDWG can
result in hypertension, left ventricular hypertrophy, car-
diac failure, and pulmonary congestion [25]. Although
data on this aspect are scarce, a recent study in periton-
eal dialysis patients suggests that intensive nursing care
(including education on fluid management, home blood
pressure measurements and intensified antihypertensive
treatment) could reduce the seasonal differences in blood
pressure [26]. Given the relatively large effect of influenza
epidemics on cardiac mortality in the general population,
special attention to vaccination for influenza and possibly
pneumococcus in this vulnerable population appears
warranted [27]. Also cholecalciferol supplementation par-
ticularly during sun-deprived seasons in temperate zones
was shown to have a beneficial effect on inflammatory
and cardiac parameters [28]. However, future studies
should address whether the increased mortality during
winter in temperate zones is amendable to intervention.
Finally, seasonal differences in mortality may be of im-
portance in the design of clinical trials and the interpret-
ation of their results.
Our study has various limitations. Aside from to the
absence of data on ambient temperatures, the division in
geographical zones and regions is only a rough proxy of
climatological and geographical differences. Therefore
differences between smaller geographical regions are not
captured in this study. In addition, despite the fact that
the MONDO consortium includes countries within dif-
ferent geographical zones and the results presented here
draw on the currently most diverse international patient-
level hemodialysis data, they certainly do not reflect the
global hemodialysis population and many important coun-
tries with large dialysis populations are currently missing
or underrepresented. For example, neither dialysis clinics
from Japan nor the large corporate US hemodialysis pro-
viders are members of the MONDO initiative. Moreover,
because of data logistics and availability some MONDO
data, in particular data from a large German provider and
some smaller academic providers, were not included in
the current analysis. For this reason, the data came pri-
marily from three large and one medium-sized corporate
dialysis provider. Despite that limitation we feel that
geographical coverage and patient diversity are sufficient
to support our conclusions. Nevertheless, it would be in-
teresting to conduct a comparable study including public
and academic dialysis centers. Another limitation is that
we could not report the mortality rates by causes of death.
Also, within each geographical area there is likely to be
variation in mortality rates between providers. However,
strict provider compliance regulations prevent the publi-
cation of their mortality rates. The cosinor method esti-
mates parameters representing cyclic events by computing
a least squares fit of a cosine function. While widely and
successfully used in the analysis of seasonal data, the
cosine method has certain shortcomings; for example, the
parameter estimates may be biased if the raw data sub-
stantially depart from a cosine function. However, the
fact that visual inspection of the data indicated sea-
sonal patterns motivated and reassured us to use the
cosinor method.
Conclusion
In this large global dialysis study we observed significant
variations in seasonal mortality, with highest value in
winter. These differences appeared more pronounced in
temperate as compared to tropical climate zones. Also,
at a global level, marked seasonal patterns of key clinical
and laboratory parameters, were observed with higher
levels of pre-SBP, IDWG, serum albumin and CRP levels
in winter as compared to summer.
Additional file
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